Observed-expected differences in life expectancy during the COVID-19 pandemic

Abstract Background Although Japan effectively controlled COVID-19 in 2020 and 2021 through public health efforts, mortality surged in 2022, possibly due to low herd immunity. In contrast, countries like the UK exhibited different trends. This study aims to clarify the impact of COVID-19 on life expectancy by analyzing the relationship between the early and later phases of the pandemic. Methods We analyzed life expectancy (LE) data from approximately 200 countries and the EU27. Expected LE values for 2020 to 2022 were projected using linear regression based on data from 2015 to 2019. Observed-expected differences (OED) were then calculated for each year. Results OEDs in 2020 and 2022 were as follows: Australia (+0.21, -0.05), New Zealand (+0.19, +0.50), Norway (+0.17, -0.93), Hong Kong (+0.12, -2.22), Denmark (+0.09, -0.51), Japan (+0.06, -0.77), South Korea (+0.05, -1.29), Finland (-0.13, -1.19), France (-0.81, -1.07), EU27 (-1.03, -1.17), UK (-1.16, +0.37), US (-1.75, -1.36), and Kuwait (-2.85, +0.43). Correlation coefficients of OEDs between 2020 and 2022 were -0.166 (p = 0.33) for very high-income countries (GNI per capita > $40,000), and significantly positive for upper-middle (0.468, p < 0.001), middle (0.532, p < 0.001), and low-income (0.612, p < 0.001) countries. Conclusions In some countries, life expectancy exceeded expected values in 2020 despite the pandemic, but most experienced negative deviations by 2022. Among very high-income countries, the negative, though non-significant, correlation between 2020 and 2022 suggests challenges in sustaining effective long-term pandemic control and the possible consequences of low herd immunity. In contrast, among countries other than very high-income countries, those that implemented effective control measures in the early phase tended to show better outcomes in the later phase, suggesting that early pandemic response can have lasting positive effects. Key messages • In some countries, life expectancy exceeded expected values in 2020 despite the COVID-19 pandemic. • By 2022, life expectancy in most of those countries had dropped below projected levels, reflecting possible delayed impacts.

Institutions

Publication Details

Journal
European Journal of Public Health
Published
2025-10-01
DOI
https://doi.org/10.1093/eurpub/ckaf161.1821
Primary Topic
COVID-19 and healthcare impacts
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Observed-expected differences in life expectancy during the COVID-19 pandemic

European Journal of Public Health
COVID-19 and healthcare impacts
article

Observed-expected differences in life expectancy during the COVID-19 pandemic

article en

Abstract

Abstract Background Although Japan effectively controlled COVID-19 in 2020 and 2021 through public health efforts, mortality surged in 2022, possibly due to low herd immunity. In contrast, countries like the UK exhibited different trends. This study aims to clarify the impact of COVID-19 on life expectancy by analyzing the relationship between the early and later phases of the pandemic. Methods We analyzed life expectancy (LE) data from approximately 200 countries and the EU27. Expected LE values for 2020 to 2022 were projected using linear regression based on data from 2015 to 2019. Observed-expected differences (OED) were then calculated for each year. Results OEDs in 2020 and 2022 were as follows: Australia (+0.21, -0.05), New Zealand (+0.19, +0.50), Norway (+0.17, -0.93), Hong Kong (+0.12, -2.22), Denmark (+0.09, -0.51), Japan (+0.06, -0.77), South Korea (+0.05, -1.29), Finland (-0.13, -1.19), France (-0.81, -1.07), EU27 (-1.03, -1.17), UK (-1.16, +0.37), US (-1.75, -1.36), and Kuwait (-2.85, +0.43). Correlation coefficients of OEDs between 2020 and 2022 were -0.166 (p = 0.33) for very high-income countries (GNI per capita > $40,000), and significantly positive for upper-middle (0.468, p < 0.001), middle (0.532, p < 0.001), and low-income (0.612, p < 0.001) countries. Conclusions In some countries, life expectancy exceeded expected values in 2020 despite the pandemic, but most experienced negative deviations by 2022. Among very high-income countries, the negative, though non-significant, correlation between 2020 and 2022 suggests challenges in sustaining effective long-term pandemic control and the possible consequences of low herd immunity. In contrast, among countries other than very high-income countries, those that implemented effective control measures in the early phase tended to show better outcomes in the later phase, suggesting that early pandemic response can have lasting positive effects. Key messages • In some countries, life expectancy exceeded expected values in 2020 despite the COVID-19 pandemic. • By 2022, life expectancy in most of those countries had dropped below projected levels, reflecting possible delayed impacts.

European Journal of Public HealthVol. 35(Supplement_4)
Hamamatsu University (JP), Inserm (FR), Kyoto University (JP), Hamamatsu University School of Medicine (JP), Kyoto Prefectural University of Medicine (JP), Office of Readiness and Response (US), Institute for Neurosciences of Montpellier (FR), Municipal Hirakata City Hospital (JP)
Openalex Percentile: Top 36%
COVID-19 and healthcare impacts
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.